Published in Cancer on June 01, 1977
Intrinsic subtypes of gastric cancer, based on gene expression pattern, predict survival and respond differently to chemotherapy. Gastroenterology (2011) 2.36
Role of intestinal metaplasia in the histogenesis of gastric carcinoma. J Clin Pathol (1980) 2.05
Association of ERBB2 gene status with histopathological parameters and disease-specific survival in gastric carcinoma patients. Br J Cancer (2009) 1.82
Incomplete sulphomucin-secreting intestinal metaplasia for gastric cancer. Preliminary data from a prospective study from three centres. Gut (1985) 1.64
Prognostic implications of type and density of tumour-infiltrating lymphocytes in gastric cancer. Br J Cancer (2008) 1.62
Prognostic value of proliferating cell nuclear antigen in gastric carcinoma. J Clin Pathol (1991) 1.46
RHOA mutation in diffuse-type gastric cancer: a comparative clinicopathology analysis of 87 cases. Gastric Cancer (2015) 1.45
Gastric carcinoma in young adults. Ann Surg (1988) 1.32
Multifactorial etiology of gastric cancer. Methods Mol Biol (2012) 1.29
Variants of intestinal metaplasia in the evolution of chronic atrophic gastritis and gastric ulcer. A follow up study. Gut (1990) 1.20
Signet-ring cell carcinoma of the stomach: Impact on prognosis and specific therapeutic challenge. World J Gastroenterol (2015) 1.17
Genetic classification of intestinal-type and diffuse-type gastric cancers based on chromosomal loss and microsatellite instability. Virchows Arch (2003) 1.15
Reproducibility of histologic classification of gastric cancer. Br J Cancer (1991) 1.13
Comparison of CT and 18F-FDG pet for detecting peritoneal metastasis on the preoperative evaluation for gastric carcinoma. Korean J Radiol (2006) 1.08
The prognostic significance of the accumulation of p53 tumour-suppressor gene protein in gastric adenocarcinoma. Br J Cancer (1994) 1.04
Endogenous estrogen exposure in relation to distribution of histological type and estrogen receptors in gastric adenocarcinoma. Gastric Cancer (2008) 1.04
Clinical implications of metastatic lymph node ratio in gastric cancer. BMC Cancer (2007) 1.03
Prognostic significance of mucin expression in gastric carcinoma. Dig Dis Sci (2004) 1.03
The clinicopathological features of gastric carcinomas with microsatellite instability may be mediated by mutations of different "target genes": a study of the TGFbeta RII, IGFII R, and BAX genes. Am J Pathol (1998) 1.00
Stomach microbiota composition varies between patients with non-atrophic gastritis and patients with intestinal type of gastric cancer. Sci Rep (2014) 0.99
Expression of UDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase-6 in gastric mucosa, intestinal metaplasia, and gastric carcinoma. J Histochem Cytochem (2008) 0.99
Tumor microsatellite instability in early onset gastric cancer. J Mol Diagn (2005) 0.98
Pathological prognostic factors in the second British Stomach Cancer Group trial of adjuvant therapy in resectable gastric cancer. Br J Cancer (1995) 0.98
Double contrast-enhanced ultrasonography evaluation of preoperative Lauren classification of advanced gastric carcinoma. Arch Med Sci (2011) 0.98
Increase in the circulating level of hepatocyte growth factor in gastric cancer patients. Br J Cancer (1997) 0.95
Helicobacter pylori and Epstein-Barr virus infection and the p53 tumour suppressor pathway in gastric stump cancer compared with carcinoma in the non-operated stomach. J Clin Pathol (1998) 0.93
Goseki histological grading of gastric cancer is an important predictor of outcome. Gut (1994) 0.93
CDH1/E-cadherin germline mutations in early-onset gastric cancer. J Med Genet (2006) 0.92
Pathohistological classification systems in gastric cancer: diagnostic relevance and prognostic value. World J Gastroenterol (2014) 0.92
Influence of pathological tumour variables on long-term survival in resectable gastric cancer. Br J Cancer (2002) 0.91
Clinical value of extended biologic staging by bone marrow micrometastases and tumor-associated proteases in gastric cancer. Ann Surg (1997) 0.91
Early signet ring cell gastric cancer. Dig Dis Sci (2010) 0.89
Assessment of microsatellite instability status for the prediction of metachronous recurrence after initial endoscopic submucosal dissection for early gastric cancer. Br J Cancer (2006) 0.89
The Reliability of Endoscopic Biopsies in Assessing HER2 Status in Gastric and Gastroesophageal Junction Cancer: A Study Comparing Biopsies with Surgical Samples. Transl Oncol (2013) 0.88
Immunohistochemical expression of tenascin in normal stomach tissue, gastric carcinomas and gastric carcinoma in lymph nodes. Br J Cancer (1995) 0.88
Gastric cancer: prevention, risk factors and treatment. Gastroenterol Hepatol Bed Bench (2011) 0.87
Clinicopathologic significance of sialyl Le(x) expression in advanced gastric carcinoma. Br J Cancer (2000) 0.87
Clinicopathological significance of claudin-4 in gastric carcinoma. World J Surg Oncol (2013) 0.86
In vivo expression of Helicobacter pylori virulence genes in patients with gastritis, ulcer, and gastric cancer. Infect Immun (2011) 0.86
MUC5B expression in gastric carcinoma: relationship with clinico-pathological parameters and with expression of mucins MUC1, MUC2, MUC5AC and MUC6. Virchows Arch (2004) 0.85
Histological grading in gastric cancer by Ming classification: correlation with histopathological subtypes, metastasis, and prognosis. World J Surg (2005) 0.85
p53 abnormalities in adenocarcinoma of the gastric cardia and antrum. Mol Pathol (1999) 0.85
Expression of sialyl-Tn in gastric cancer: correlation with known prognostic factors. Br J Cancer (1995) 0.84
Clinicopathologic characteristics and prognostic value of various histological types in advanced gastric cancer. Int J Clin Exp Pathol (2014) 0.84
Inhibition of gastric cancer cell proliferation by antisense oligonucleotides targeting the messenger RNA encoding proliferating cell nuclear antigen. Br J Cancer (1994) 0.83
[Molecular pathology of gastric cancer]. Pathologe (2012) 0.83
A combined histologic and molecular approach identifies three groups of gastric cancer with different prognosis. Virchows Arch (2009) 0.82
Clinicopathologic and prognostic characterization of poorly differentiated medullary-type gastric adenocarcinoma. World J Surg (2004) 0.82
Intestinal and diffuse types of gastric cancer: secular trends in Sweden since 1951. Br J Cancer (1991) 0.81
SIRT3 expression as a biomarker for better prognosis in gastric cancer. World J Surg (2014) 0.81
Reverse Correlation between MicroRNA-145 and FSCN1 Affecting Gastric Cancer Migration and Invasion. PLoS One (2015) 0.80
Requirement for a standardised definition of advanced gastric cancer. Oncol Lett (2013) 0.80
Prognostic value of Goseki histological classification in adenocarcinoma of the cardia. Br J Cancer (2003) 0.80
Signet ring cell histology is not an independent predictor of poor prognosis after curative resection for gastric cancer: a propensity analysis by the KLASS Group. Medicine (Baltimore) (2014) 0.80
Claudin-1, but not claudin-4, exhibits differential expression patterns between well- to moderately-differentiated and poorly-differentiated gastric adenocarcinoma. Oncol Lett (2015) 0.79
Is signet-ring cell carcinoma a specific entity among gastric cancers? Gastric Cancer (2015) 0.78
Gastric Mucinous Cancer Histology: Clinicopathological Characteristics and Prognostic Value. Gastroenterol Res Pract (2015) 0.78
Improvements in diagnosis have changed the incidence of histological types in advanced gastric cancer. Br J Cancer (1995) 0.77
Human chorionic gonadotrophin beta expression in malignant Barrett's oesophagus. Virchows Arch (2004) 0.77
[Ways to personalized medicine for gastric cancer]. Pathologe (2013) 0.76
LINE-1 family member GCRG123 gene is up-regulated in human gastric signet-ring cell carcinoma. World J Gastroenterol (2008) 0.76
The characteristics and prognostic value of signet ring cell histology in gastric cancer: A retrospective cohort study of 2199 consecutive patients. Medicine (Baltimore) (2016) 0.75
Early gastric cancer in Korea. Korean J Intern Med (1989) 0.75
Three Molecular Subtypes of Gastric Adenocarcinoma Have Distinct Histochemical Features Reflecting Epstein-Barr Virus Infection Status and Neuroendocrine Differentiation. Appl Immunohistochem Mol Morphol (2015) 0.75
miR-15a-3p and miR-16-1-3p Negatively Regulate Twist1 to Repress Gastric Cancer Cell Invasion and Metastasis. Int J Biol Sci (2017) 0.75
Gastric cancer. Postgrad Med J (1996) 0.75
[Grading of tumors in the tubular digestive tract : Esophagus, stomach, colon and rectum]. Pathologe (2016) 0.75
Prognostic risk factors of early gastric cancer-a western experience. Langenbecks Arch Surg (2016) 0.75
Prognostic implication of infiltrative growth pattern and establishment of novel risk stratification model for survival in patients with upper urinary tract urothelial carcinoma. Int J Clin Oncol (2013) 0.75
[Tumor classifications]. Pathologe (2004) 0.75
Hemorrhagic necrosis of the gastrointestinal tract and its relation to cardiovascular status. Circulation (1965) 1.45
Intestinal metaplasia and histogenesis of carcinoma in human stomach. Light and electron microscopic study. Cancer (1967) 1.30
Gastric dysplasia. Significance and pathologic criteria. Cancer (1984) 1.23
Mucins in normal and neoplastic gastrointestinal epithelium. Histochemical distribution. Arch Pathol (1968) 1.22
Expression of c-myc and other cell cycle-dependent genes in human colon neoplasia. Cancer Res (1985) 1.09
Growth-dependent expression of human Mr 53,000 tumor antigen messenger RNA in normal and neoplastic cells. Cancer Res (1986) 0.98
Fine structure of intestinal metaplasia and adenocarcinoma of the human stomach. Lab Invest (1968) 0.96
Mixed hyperplastic and adenomatous polyp arising from ectopic gastric mucosa of the duodenum. Arch Pathol Lab Med (1986) 0.89
Dysplasia of gastric epithelium. Front Gastrointest Res (1979) 0.88
Pathology and ploidy in the prognosis of gastric cancer with no extranodal metastasis. Cancer (1994) 0.86
Inhibitory effect of lymphocytes on DNA synthesis of target cells in vitro. Ann Med Exp Biol Fenn (1966) 0.86
The classification and significance of gastric polyps. Monogr Pathol (1977) 0.83
Inhibition of DNA synthesis of target cells in vitro by sensitized lymphocytes. Nature (1967) 0.83
Vasomotor factors in the Shwartzman phenomenon. Am J Pathol (1969) 0.82
II. Malignant potential of gastric polyps. Gastrointest Radiol (1976) 0.81
Acute ischemic changes in intestinal muscularis. Am J Pathol (1976) 0.78
The importance of follow-up studies in gastric dysplasia: the pathologist's view. Endoscopy (1993) 0.78
Fatal corpus luteum hemorrhage during anticoagulant therapy. Obstet Gynecol (1971) 0.75
The role of cytology in the diagnosis of carcinoma of the stomach. Surg Gynecol Obstet (1980) 0.75
Cancer of the gastrointestinal tract. Histogenesis and premalignant lesions. JAMA (1974) 0.75
Differential diagnosis of hemorrhagic necrosis of the digestive tract and mesenteric thrombosis. Med Times (1967) 0.75
The role of cytologic studies in the diagnosis of carcinoma of the stomach. Curr Surg (1982) 0.75
Evolution of lesions in intestinal ischemia. Arch Pathol Lab Med (1977) 0.75